Health Insurance (Accredited Pathology Laboratories Approval) Amendment Principles 2013 (No. 1) (Cth)
Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2013 (No.1)
Health Insurance Act 1973
I, Richard Bartlett, delegate of the Minister for Health, make these Principles under subsection 23DNA (1) of the Health Insurance Act 1973.
Dated 25 November 2013
Richard Bartlett
First Assistant Secretary
Medical Benefits Division
Department of Health
Name of Principles
These Principles are the Health Insurance (Accredited Pathology Laboratories – Approval) Amendment Principles 2013 (No.1).
Commencement
These Principles commence on 1 December 2013.
3 Authority
These Principles are made under subsection 23DNA(1) of the Health Insurance Act 1973.
4 Schedule
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1 Amendment
Health Insurance (Accredited Pathology Laboratories ― Approval) Principles 2002
Schedule 1
substitute
Schedule 1 Accreditation materials
(section 5)
Part 1 NPAAC materials
| Item | Material | Publication Year |
| 1 | Requirements for Medical Pathology Services (First Edition 2013) | 2013 |
| 2 | Requirements for Procedures Related to the Collection, Processing, Storage and Issue of Human Haemopoietic Progenitor Cells (Fourth Edition 2013) | 2013 |
| 3 | Requirement for the Facilities and Operation of Mortuaries (Third Edition 2013) | 2013 |
| 4 | Requirements for Enrolment and Participation in External Quality Assessment (Fifth Edition 2013) | 2013 |
| 5 | Guidelines for Approved Pathology Collection Centres (Requirements for Medical Pathology Specimen Collection) (Third Edition 2013) | 2013 |
| 6 | Requirements for the Performance of Anatomical Pathology Cut-Up (Fourth Edition 2013) | 2013 |
| 7 | Guidelines for the use of Liquid Based Collection Systems and Semi‑Automated Screening Devices in the Practice of Gynaecological (Cervical) Cytology | 2006 |
| 8 | Requirements for Medical Testing of Human Nucleic Acids (Second Edition 2013) | 2013 |
| 9 | Performance Measures for Australian Laboratories Reporting Cervical Cytology | 2006 |
| 10 | Requirements for Gynaecological (Cervical) Cytology | 2006 |
| 11 | Requirements for the Supervision of Pathology Laboratories | 2007 |
| 12 | Requirements for Laboratory Testing for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) (Third Edition 2013) | 2013 |
| 13 | Requirements for Medical Testing of Microbial Nucleic Acids (Second Edition 2013) | 2013 |
| 14 | Requirements for Cytogenetic Testing (Second Edition 2013) | 2013 |
| 15 | Requirements for Information Communication (Third Edition 2013) | 2013 |
| 16 | Requirements for the Packaging and Transport of Pathology Specimens and Associated Materials (Third Edition 2013) | 2013 |
| 17 | Requirements for the Development and Use of In‑house In Vitro Diagnostic Devices (IVDs) | 2007 |
| 18 | Requirements for the Estimation of Measurement Uncertainty | 2007 |
| 19 | Requirements for the Retention of Laboratory Records and Diagnostic Material (Sixth Edition 2013) | 2013 |
| 20 | Requirements for Transfusion Laboratory Practice (Second Edition 2013) | 2013 |
Note The documents mentioned in Part 1 are available on the Internet — see 2 Supplementary materials
Interpretation of NPAAC Requirements and ISO 15189 Medical Testing Field Application document – Requirements for Accreditation, July 2013
Note The document mentioned in item 1 is available from the National Association of Testing Authorities – see
0
0
0